# US 2012/0253273 A1 · Needleless injector drug capsule and a method for filling thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253273 A1
- Document ID: US20120253273A1
- Status: Published application
- Kind: A1
- Application number: 13/495,390
- Filed: 2012-06-13
- Published: 2012-10-04
- Earliest claimed: 2001-11-21
- Assignees: Zogenix, Inc.
- Inventors: WILLIAM HENRY; ANDREW LEWIS
- Web page: https://patentgrep.com/patent/US20120253273A1

## CPC

- A61M 5/30: Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
- B01D 19/0005: {with one or more auxiliary substances}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)

## Abstract

A method for tilling needleless injector capsules with liquid drug, whereby dissolved gas within the drug is replaced by a less soluble gas in order to reduce the inclusion of gas bubbles, or to prevent the growth of bubbles during storage and thereby prevent breakage of the capsules.

## Claims

### Claim at position 1

-26. (canceled)

### Claim 27

A needle free injector drug capsule, comprising:
a container comprised of borosilicate glass; and
a liquid formulation in the container, wherein the liquid formulation is comprised of a drug, and the liquid formulation has been purged by an inert gas soluble in the liquid formulation.

### Claim 28 (depends on 27)

The needle free injector drug capsule of claim 27, wherein the inert gas solubility in the formulation over a range of temperatures from 0° C. to 30° C. is such that the inert gas does not come out of solution during temperature cycling.

### Claim 29 (depends on 28)

A needle free injector drug capsule as claimed in claim 28, wherein the inert gas is selected from the group consisting of helium, argon, neon, krypton, xenon, nitrogen, a chlorofluorocarbon, a hydrofluorocarbon, and a mixture thereof.

### Claim 30 (depends on 29)

A needle free injector drug capsule as claimed in claim 29, wherein the inert gas does not include helium.

### Claim 31 (depends on 27)

The needle free injector drug capsule of claim 27, wherein the inert gas solubility in the formulation is such that gas does not come out of solution during storage over a range of temperatures corresponding to a temperature range expected during storage.

### Claim 32 (depends on 31)

A needle free injector capsule as claimed in claim 31, wherein the range of temperatures is 0° C. to 30° C. and the glass is strengthened with ion exchange.

### Claim 33

A needle free injector drug capsule, comprising:
a container comprised of borosilicate glass strengthened with ion exchange; and
a liquid formulation in the container, wherein the liquid formulation is comprised of a drug, and the liquid formulation has been purged by an inert gas having a solubility of 0.5 cm3 to 25 cm3 in 100 cm3 of the liquid formulation;
wherein the inert gas solubility in the formulation is such that gas does not come out of solution during storage over a range of temperatures of 0° C. to 30° C.

### Claim 34 (depends on 33)

A needle free injector drug capsule as claimed in claim 33, wherein the inert gas is selected from the group consisting of helium, argon, neon, krypton, xenon, nitrogen, a chlorofluorocarbon, a hydrofluorocarbon, and a mixture thereof.

### Claim 35 (depends on 34)

A needle free injector drug capsule as claimed in claim 34, wherein the inert gas does not include helium.

### Claim 36

A needle free injector drug capsule, comprising:
a container comprised of glass strengthened with ion exchange glass; and
a liquid formulation in the container, wherein the liquid formulation is comprised of a drug, and the liquid formulation has been purged by an inert gas soluble in the liquid formulation.

### Claim 37 (depends on 36)

The needle free injector drug capsule of claim 36, wherein the inert gas solubility in the formulation over a range of temperatures from 0° C. to 30° C. is such that the inert gas does not come out of solution during temperature cycling.

### Claim 38 (depends on 37)

A needle free injector drug capsule as claimed in claim 37, wherein the inert gas is selected from the group consisting of helium, argon, neon, krypton, xenon, nitrogen, a chlorofluorocarbon, a hydrofluorocarbons, and a mixture thereof.

### Claim 39 (depends on 38)

A needle free injector drug capsule as claimed in claim 38, wherein the inert gas is helium.

### Claim 40 (depends on 36)

The needle free injector drug capsule of claim 36, wherein the inert gas solubility in the formulation is such that gas does not come out of solution during storage over a range of temperatures of from 0° C. to 30° C. and the glass is borosilicate glass.

### Claim 41

A needle free injector drug capsule, comprising:
a container comprised of glass strengthened with ion exchange glass; and
a liquid formulation in the container, wherein the liquid formulation is comprised of a drug.

### Claim 42 (depends on 41)

The needle free injector drug capsule of claim 41, wherein the liquid formulation has been purged by an inert gas soluble in the liquid formulation.

### Claim 43 (depends on 42)

The needle free injector drug capsule of claim 42, wherein the inert gas solubility in the formulation over a range of temperatures from 0° C. to 30° C. is such that the inert gas does not come out of solution during temperature cycling.

### Claim 44 (depends on 43)

The needle free injector drug capsule as claimed in claim 43, wherein the inert gas is selected from the group consisting of helium, argon, neon, krypton, xenon, nitrogen, a chlorofluorocarbon, a hydrofluorocarbon, and a mixture thereof.

### Claim 45 (depends on 44)

The needle free injector drug capsule as claimed in claim 44, wherein the inert gas is helium.

### Claim 46 (depends on 42)

The needle free injector drug capsule of claim 42, wherein the inert gas solubility in the formulation is such that gas does not come out of solution during storage over a range of temperatures of from 0° C. to 30° C. and the glass is borosilicate glass.

### Claim 47 (depends on 27)

The needle free injector drug capsule as claimed in claim 27, wherein the inert gas is helium.

### Claim 48 (depends on 33)

The needle free injector drug capsule as claimed in claim 33, wherein the inert gas is helium.
